Howmet Aerospace: The SpaceX Threat Is Overblown (Rating Upgrade)

Howmet Aerospace was upgraded to Buy following a 7.5% share-price decline attributed to concerns over SpaceX developing in-house turbine-blade casting. Howmet retains more than 50% global market share in industrial gas-turbine blades, supported by long-term contracts and capacity expansion across Japan, Europe and the U.S. The analysis views SpaceX's effort as a solution to its own supply constraint rather than a scaled competitive threat, implying limited risk to Howmet's earnings or margins.

Analysis

The relevant question is not whether a launch customer can internalize a constrained component, but whether that changes HWM's pricing power across commercial aerospace and stationary-power programs. It likely does not: qualification cycles, certification risk, and incumbent OEM sourcing structures make isolated vertical integration a poor proxy for share loss. The more investable read-through is that incremental proprietary capacity at customers can relieve bottlenecks upstream, supporting engine and turbine throughput—and therefore HWM shipment volumes—rather than displacing its core installed-base economics.

Near term, the stock can recover as the market refocuses on aerospace build-rate execution and power-generation demand rather than a speculative competitive threat. Over 1-3 months, earnings commentary on backlog conversion, casting yields, and capacity ramp utilization is the catalyst; positive evidence should support both EPS revisions and reversal of the recent sentiment-driven multiple compression. Over 6-18 months, the key upside is operating leverage if new capacity fills without material price concessions, while the principal risk is that OEM delivery delays defer revenue despite intact end demand.

The contrarian risk is valuation rather than competition. HWM is typically priced for superior execution, so even a benign competitive outcome will not protect the shares if commercial-engine deliveries, industrial gas-turbine orders, or aftermarket mix disappoint. Falsify the long thesis on a material reduction in management's aerospace or industrial-gas-turbine margin outlook, evidence of customer dual-sourcing on qualified programs, or sustained capacity underutilization; an isolated in-house effort by a private launch company is not sufficient evidence.

Key Decisions for Investors

• Initiate a 1-3 month long HWM position in tranches following the pullback; target a recovery of the event-driven discount as the next earnings update confirms backlog conversion and segment-margin resilience. Risk-manage with a 7-10% stop from average entry or exit on guidance reduction rather than headline-driven volatility.
• Prefer HWM over broad aerospace exposure: pair long HWM / short XAR in equal dollar amounts for 3-6 months if the objective is to isolate company-specific execution and power-generation exposure from broader defense-budget and aerospace-cycle beta.
• Do not express the thesis through SPCX: SpaceX is not a conventional public-equity comparable, and the stated competitive concern does not establish a measurable earnings transmission mechanism to a listed security. Treat any further claims of internal casting scale as a diligence alert until production capacity, qualification status, and external-customer strategy are independently verified.
• At the next HWM report, monitor aerospace revenue growth, segment operating margin, turbine-blade capacity utilization, and customer delivery schedules. Add only if management maintains or raises full-year margin/FCF expectations; reduce if capacity-expansion costs rise without corresponding volume conversion.